FDA Extends Enforcement Discretion On Free Phytosterol Health Claims
This article was originally published in The Tan Sheet
Executive Summary
FDA will give firms a year to relabel or reformulate dietary supplements with nonesterified phytosterols to comply with a proposed rule that overhauls a health claim linking phytosterols to a reduced risk of coronary heart disease.